This international, peer-reviewed Open Access journal by Dove Medical Press focuses on the pathological basis of cancers, potential targets for therapy and treatment protocols to improve the management of cancer patients.
OncoTargets and Therapy is an international, peer-reviewed OA journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal will also focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Follow this link for information on the Editors and the Editorial Board Members.
Open Access Publication: All manuscripts submitted to Dove Medical Press are assumed to be submitted under the Open Access publishing model.
In this publishing model, papers are peer-reviewed in the normal way under editorial control. When a paper is accepted for publication the author is issued with an invoice for payment of a publication processing fee. Publication processing fees invoiced to EU countries are subject to 20% VAT. There is no submission charge as such, only the publication processing fee after the paper is accepted for publication. Payment of this charge allows Dove Medical Press to recover its editorial and production costs and create a pool of funds that can be used to provide fee waivers for authors from lesser developed countries.
For more information on the publishing process and publishing fees follow this link.